Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie A Wagner

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Ecological Applications : a Publication of the Ecological Society of America|June 1, 2012
Corridors promote fire via connectivity and edge effectsLars A Brudvig, Stephanie A Wagner, Ellen I Damschen
American Journal of Hematology|June 29, 2007
Rituximab-induced interstitial lung diseaseStephanie A Wagner, Apurva C Mehta, Damian A Laber
The Journal of Clinical Psychiatry|February 5, 2009
Efficacy of osmotic-release oral system (OROS) methylphenidate for mothers with attention-deficit/hyperactivity disorder (ADHD): preliminary report of effects on ADHD symptoms and parentingAndrea Chronis-Tuscano, Karen E Seymour, Mark A Stein, et al.
Cancer|February 20, 2020
A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinomaSara E Kochanny, Francis P Worden, Douglas R Adkins, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|August 14, 2014
Potential negative ecological effects of corridorsNick M Haddad, Lars A Brudvig, Ellen I Damschen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2016
Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic CancerSunil R Hingorani, William P Harris, J Thaddeus Beck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2015
Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has FailedHerbert I Hurwitz, Nikhil Uppal, Stephanie A Wagner, et al.
JAMA Oncology|November 17, 2022
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort TrialLinda M Liau, Keyoumars Ashkan, Steven Brem, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Ecological Applications : a Publication of the Ecological Society of America|June 1, 2012
Corridors promote fire via connectivity and edge effectsLars A Brudvig, Stephanie A Wagner, Ellen I Damschen
American Journal of Hematology|June 29, 2007
Rituximab-induced interstitial lung diseaseStephanie A Wagner, Apurva C Mehta, Damian A Laber
The Journal of Clinical Psychiatry|February 5, 2009
Efficacy of osmotic-release oral system (OROS) methylphenidate for mothers with attention-deficit/hyperactivity disorder (ADHD): preliminary report of effects on ADHD symptoms and parentingAndrea Chronis-Tuscano, Karen E Seymour, Mark A Stein, et al.
Cancer|February 20, 2020
A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinomaSara E Kochanny, Francis P Worden, Douglas R Adkins, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|August 14, 2014
Potential negative ecological effects of corridorsNick M Haddad, Lars A Brudvig, Ellen I Damschen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2016
Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic CancerSunil R Hingorani, William P Harris, J Thaddeus Beck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2015
Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has FailedHerbert I Hurwitz, Nikhil Uppal, Stephanie A Wagner, et al.
JAMA Oncology|November 17, 2022
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort TrialLinda M Liau, Keyoumars Ashkan, Steven Brem, et al.
Pageof 1